These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 14657424)
1. Incentive-based formularies. Thomas CP N Engl J Med; 2003 Dec; 349(23):2186-8. PubMed ID: 14657424 [No Abstract] [Full Text] [Related]
2. The effect of incentive-based formularies on prescription-drug utilization and spending. Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Frank RG N Engl J Med; 2003 Dec; 349(23):2224-32. PubMed ID: 14657430 [TBL] [Abstract][Full Text] [Related]
3. Effect of incentive-based formularies on drug utilization and spending. Sandy LG; Heady T N Engl J Med; 2004 Mar; 350(10):1057. PubMed ID: 15002122 [No Abstract] [Full Text] [Related]
4. Pharmaceutical formularies: the right formula for cost and utilization? Austin B Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009 [No Abstract] [Full Text] [Related]
5. Effect of incentive-based formularies on drug utilization and spending. Shrank WH N Engl J Med; 2004 Mar; 350(10):1057. PubMed ID: 14999122 [No Abstract] [Full Text] [Related]
6. Specialty pharmacy management adjusts to new financial realities. Reinke T Manag Care; 2013 Apr; 22(4):13-4. PubMed ID: 23678558 [No Abstract] [Full Text] [Related]
7. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children. Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Muriel AC; Frank RG Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411 [TBL] [Abstract][Full Text] [Related]
8. Employers push to manage prescription drug costs. Frieden J Bus Health; 1992 May; 10(6):43-6, 48, 50. PubMed ID: 10119119 [No Abstract] [Full Text] [Related]
9. Approaches to pharmacy benefit management and the impact of consumer cost sharing. Olson BM Clin Ther; 2003 Jan; 25(1):250-72. PubMed ID: 12637125 [TBL] [Abstract][Full Text] [Related]
10. Managing prescription drug costs. Sica JM Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515 [TBL] [Abstract][Full Text] [Related]
12. Prescription drug prices in Canada. Gross D Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123 [No Abstract] [Full Text] [Related]
13. Controlling prescription drug expenditures: a report of success. Miller DP; Furberg CD; Small RH; Millman FM; Ambrosius WT; Harshbarger JS; Ohl CA Am J Manag Care; 2007 Aug; 13(8):473-80. PubMed ID: 17685828 [TBL] [Abstract][Full Text] [Related]
14. Prescription drug benefits: Rx for cost management--commentary. Carlsen MA Benefits Q; 1993; 9(3):81-8. PubMed ID: 10127207 [No Abstract] [Full Text] [Related]
15. A prescription for a modern Medicare program. Bach PB; McClellan MB N Engl J Med; 2005 Dec; 353(26):2733-5. PubMed ID: 16382056 [No Abstract] [Full Text] [Related]
16. Financial consequences of drug benefit plans. Motheral B; Sheth J JAMA; 2003 Jan 22-29; 289(4):423-4; author reply 424. PubMed ID: 12533119 [No Abstract] [Full Text] [Related]
17. Financial consequences of drug benefit plans. Hsu J; Reed M JAMA; 2003 Jan 22-29; 289(4):423; author reply 424. PubMed ID: 12533118 [No Abstract] [Full Text] [Related]
18. Financial consequences of drug benefit plans. Clark BE; Garis RI JAMA; 2003 Jan 22-29; 289(4):423; author reply 424. PubMed ID: 12533117 [No Abstract] [Full Text] [Related]
19. New concepts in health benefits. Three-tier drug copays. Reese S Bus Health; 2000 Apr; 18(4):29-30, 32, 35. PubMed ID: 10915290 [No Abstract] [Full Text] [Related]